O19: Integrated analyses of data from clinical trials of delandistrogene moxeparvovec gene therapy in DMD*

• Erin O’Rourke,
• Crystal Proud,
• Craig Zaidman,
• Perry B. Shieh,
• Craig McDonald,
• John W. Day,
• Stefanie Mason,
• Maitea Guridi,
• Lixin Han,
• Lixi Yu,
• Carol Reid,
• Eddie Darton,
• Christoph Wandel,
• James Richardson,
• Jyoti Malhotra,
• Teji Singh,
• Louise Rodino-Klapac,
• Jerry Mendell

Affiliations

Erin O’Rourke

Sarepta Therapeutics, Inc.

Crystal Proud

Children’s Hospital of the King’s Daughters

Craig Zaidman

Department of Neurology, WUSTL

Perry B. Shieh

UCLA Medical Center

Craig McDonald

UC Davis Health

John W. Day

Department of Neurology, Stanford University

Stefanie Mason

Sarepta Therapeutics, Inc.

Maitea Guridi

F. Hoffmann-La Roche Ltd

Lixin Han

Sarepta Therapeutics, Inc.

Lixi Yu

Sarepta Therapeutics, Inc.

Carol Reid

Roche Products Ltd

Eddie Darton

Sarepta Therapeutics, Inc.

Christoph Wandel

F. Hoffmann-La Roche Ltd

James Richardson

Sarepta Therapeutics, Inc.

Jyoti Malhotra

Sarepta Therapeutics, Inc.

Teji Singh

Sarepta Therapeutics, Inc.

Louise Rodino-Klapac

Sarepta Therapeutics, Inc.

Jerry Mendell

Center for Gene Therapy, Nationwide Children’s Hospital